Lin Chen is the Manager, Process Development, at CordenPharma Colorado. He obtained his PhD with Professor George Barany from University of Minnesota at Twin Cities. After working on high throughput peptide synthesis for several years at Axcell Biosciences, a Cytogen subsidiary on the east coast, he joined Roche Colorado Corporation in Boulder to begin his API process development career. He was a Distinguished Scientist when CordenPharma acquired the Roche facility in Boulder. Dr. Lin Chen has more than 20 years of GMP process development experience, especially in the field of synthetic peptides.
